Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.

Anli YangZhiyong GuoQingqi RenLinwei WuYi MaAnbin HuDongping WangHaidan YeXiaofeng ZhuWeiqiang JuXiaoshun He

Published in: PloS one (2017)

Active immunization is an effective, cost-saving, and safe method for the prevention of HBV reactivation in patients transplanted for hepatitis B virus related liver diseases. The LY/EO rate may be a valuable indicator in selecting potential recipients for vaccination.

Keyphrases

hepatitis b virus
end stage renal disease
ejection fraction
liver failure
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
climate change
risk assessment
drug induced